Brief: ExpreS2ion Announces Selection Of AGC Biologics As Manufacturing Partner For Covid-19 Vaccine; Provides Update To Program

ExpreS2ion Biotech Holding AB

24/04/2020 07:59

April 24 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES SELECTION OF AGC BIOLOGICS AS
MANUFACTURING
PARTNER FOR THE COVID-19 VACCINE AND PROVIDES UPDATE TO THE
PROGRAM
    * PARTNERSHIP BETWEEN ADAPTVAC AND AGC BIOLOGICS HAS
POTENTIAL TO
ADVANCE INITIATION OF FIRST CLINICAL TRIAL TO END OF 2020
    * VACCINE FORMULATION IS CURRENTLY ON-GOING, AND CONSORTIUM
HAS
ALREADY INITIATED INITIAL IN VIVO EXPERIMENTS, WHICH WILL ALLOW
SELECTION OF FINAL VACCINE CANDIDATE
    * OUTCOME OF THESE CAN BE EXPECTED AT START OF Q3 2020

Source text for Eikon:  ID:nWkrNTm2w 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))